# Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

> **NCT02754518** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 40 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Entresto

## Key facts

- **NCT ID:** NCT02754518
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02754518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02754518, "Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02754518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*